surmount trials tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The SURMOUNT-MAINTAIN Phase 3b trial

Ozempic has been used off-label to treat conditions like PCOS

For now, the most evidence-based approach is cautious: L-theanine supplements are not well studied enough in pregnancy to recommend routinely, while moderate tea intake is usually the more reasonable food-first option

In STEP UP il 6,0% dei partecipanti trattati con semaglutide 2,4 mg ha segnalato eventi di disestesia, contro il 22,9% con 7,2 mg

Its recommended to increase the dose gradually (every four weeks) if additional blood sugar management is needed

22 One study had moderate concerns with a low participation rate, no confounder adjustment, and moderate risks in selection of participants and reported results, as well as deviations from intended interventions (ESM eFig

Initially indicated for type 2 diabetes mellitus, Tirzepatide promotes glycemic control and weight loss through incretin-mediated insulin secretion and appetite suppression